Case report: High-dose epoprostenol therapy in pediatric patients with pulmonary hypertension and developmental lung disease

• Main Authors: Yoshie Fukasawa (Author), Hidenori Yamamoto (Author), Miharu Ito (Author), Akiko Saito (Author), Kiyotaka Go (Author), Yoshihito Morimoto (Author), Kazushi Yasuda (Author), Yoshiaki Sato (Author), Masahiro Hayakawa (Author), Taichi Kato (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pulmonary hypertension (PH) with developmental lung disease is a life-threatening disease and accounts for 10%-12% of pediatric PH patients. Administration of specific pulmonary vasodilators to pediatric PH patients has brought about improvement of their long-term prognosis. Intravenous epoprostenol...